1557 |
Experiences of 2nd Generation OCT in Assessment of Complex Coronary Lesions; Can It Give Us Additive Useful Information? |
Alan C. Yeung |
May. 13. 11 |
1556 |
2nd Generation OCT: Recent Advances and Future Direction |
Wang-Yuhl Oh |
May. 13. 11 |
1555 |
Advantage of 2nd Generation OCT; OCT Is Useful to Assess Complex Coronary Lesions |
Gary S. Mintz |
May. 13. 11 |
1554 |
Impact of Complete Revascularization Strategy |
Young-Hak Kim |
May. 13. 11 |
1553 |
What We Will Learn from FREEDOM and ISCHEMIA Trials ? |
Mun Kyung Hong |
May. 13. 11 |
1552 |
Does High SYNTAX Score Always Means Bypass Surgery in Multivessel Disease Patients ? |
Imad Sheiban |
May. 13. 11 |
1551 |
Asymptomatic Carotid Stenosis: Optimal Medical Treatment vs. Revascularization |
Jae-Hwan Lee |
May. 13. 11 |
1550 |
Is Protection Device of Benefit or Not ? |
Hsien-Li Kao |
May. 13. 11 |
1549 |
Normal Risk Symptomatic Patients, On-going Debate; CAS vs CEA? |
John R. Laird |
May. 13. 11 |
1548 |
IVUS-FFR: Optimal Cut-off of MLA |
Soo-Jin Kang |
May. 13. 11 |